Breaking News] Gyeonggi Provincial Office of Education's Education Administration Information System Nice Some Obstacles ▶ ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025Reiterate cash runway into mid-2026; Q3 2024 ending ...

EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

Suvoda, a global clinical trial technology company specializing in complex studies in therapeutic areas like oncology, ...

The court has decided not to allow Lee Jae-myung, chairman of the Democratic Party of Korea, to film or broadcast the first ...

Q3 2024 Earnings Call Transcript November 6, 2024 UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.55, ...

Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ETCompany ParticipantsLauren Marek - LifeSci AdvisorsLaura Niklason ...

President-elect Donald Trump spoke publicly for the first time since winning the White House at the America First Policy ...

James Quinlan joins Cooper Levenson, enhancing its litigation team with decades of expertise in corporate law, complex ...

On track to report interim data in six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC in 4Q 2024Expect to report interim ...

The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have ...

One of the easiest ways of running Windows apps is to use a virtual machine. This involves running Windows on top of macOS by ...